The evolution of patient needs and rising consumer expectations are shaping a new era in healthcare — one that calls for a ...

White will work on initiatives that showcase the company’s work in the field of generative biology, the company said in a ...

It might seem like common sense to not leave children in a hot car, but there are plenty of misconceptions around how these ...

When he arranged to undergo top surgery, Cass Smith-Collins of Las Vegas selected a surgeon touted as an early developer of ...

The report exposes jarring gaps in workplace safety, working hours and mental health, as well as career progression barriers ...

As a result of its strong topline performance, Eli Lilly raised its full year revenue guidance by $2 billion to the range of ...

Globally, Havas increased its revenue from €611m to €649m in Q1 2024, a 6.2% increase on Q1 2023.

But a recent Florida Supreme Court ruling paved the way for the Sunshine State to enforce a six-week ban beginning in May, ...

If the industry rumour mill is to be believed, a takeover of one of the “big six” agency groups or even a merger between two ...

After experiencing a brief boost during the COVID-19 pandemic, the pharma industry’s reputation has begun to drop again in ...

Real Chemistry launched IRIS, a predictive analytics platform using AI to provide insights on GLP-1 drugs and the obesity ...

The $2.4 billion deal will bring Deciphera’s cancer drugs Qinlock, vimseltinib and DCC-3116 under Ono Pharmaceutical’s ...